The DOI matches its Crossref record; 247 of the 247 references it cites were found in a registry or an index.
Cervical Cancer Screening Programs in Europe: The Transition Towards HPV Vaccination and Population-Based HPV Testing
Open accessAbstract
Cervical cancer is the fourth most frequently occurring cancer in women around the world and can affect them during their reproductive years. Since the development of the Papanicolaou (Pap) test, screening has been essential in identifying cervical cancer at a treatable stage. With the identification of the human papillomavirus (HPV) as the causative agent of essentially all cervical cancer cases, HPV molecular screening tests and HPV vaccines for primary prevention against the virus have been developed. Accordingly, comparative studies were designed to assess the performance of cervical cancer screening methods in order to devise the best screening strategy possible. This review critically assesses the current cervical cancer screening methods as well as the implementation of HPV vaccination in Europe. The most recent European Guidelines and recommendations for organized population-based programs with HPV testing as the primary screening method are also presented. Lastly, the current landscape of cervical cancer screening programs is assessed for both European Union member states and some associated countries, in regard to the transition towards population-based screening programs with primary HPV testing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Epidemiologic classification of human papillomavirus types associated with cervical cancer
Muñoz, N., Bosch, F. X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K. V., Snijders, P. J. F., & Meijer, C. J. L. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021641 · Cited by 6,249
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
Ferlay, J., Steliarova-Foucher, E., Lortet-Tieulent, J., Rosso, S., Coebergh, J. W. W., Comber, H., Forman, D., & Bray, F. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.12.027 · Cited by 5,263
Dürst, M., Gissmann, L., Ikenberg, H., & zur Hausen, H. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.12.3812 · Cited by 2,025
Global estimates of cancer prevalence for 27 sites in the adult population in 2008
Bray, F., Ren, J., Masuyer, E., & Ferlay, J. (2013) · International Journal of Cancer · doi:10.1002/ijc.27711 · Cited by 1,891
Ronco, G., Dillner, J., Elfström, K. M., Tunesi, S., Snijders, P. J. F., Arbyn, M., Kitchener, H., Segnan, N., Gilham, C., Giorgi-Rossi, P., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62218-7 · Cited by 1,810
Smith, J. S., Lindsay, L., Hoots, B., Keys, J., Franceschi, S., Winer, R., & Clifford, G. M. (2007) · International Journal of Cancer · doi:10.1002/ijc.22527 · Cited by 1,686
Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis
Clifford, G. M., Smith, J. S., Plummer, M., Muñoz, N., & Franceschi, S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600688 · Cited by 1,561
NATURAL HISTORY OF CERVICAL INTRAEPITHELIAL NEOPLASIA
RICHART, R. M. (1967) · Clinical Obstetrics and Gynecology · doi:10.1097/00003081-196712000-00002 · Cited by 1,376
Natural History of Cervical Intraepithelial Neoplasia: A Critical Review
Östör, A. G. (1993) · International Journal of Gynecological Pathology · doi:10.1097/00004347-199304000-00018 · Cited by 1,260
Ronco, G., Giorgi-Rossi, P., Carozzi, F., Confortini, M., Palma, P. D., Del Mistro, A., Ghiringhello, B., Girlando, S., Gillio-Tos, A., De Marco, L., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70360-2 · Cited by 936
Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
Arbyn, M., Ronco, G., Anttila, A., Meijer, C. J. L. M., Poljak, M., Ogilvie, G., Koliopoulos, G., Naucler, P., Sankaranarayanan, R., & Peto, J. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.06.095 · Cited by 897
Meites, E., Kempe, A., & Markowitz, L. E. (2016) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6549a5 · Cited by 802
The Bethesda System for Reporting Cervical Cytology: Definitions, Criteria, and Explanatory Notes
(2015) · Springer eBooks · doi:10.1007/978-3-319-11074-5 · Cited by 801
Arbyn, M., Anttila, A., Jordan, J., Ronco, G., Schenck, U., Segnan, N., Wiener, H., Herbert, A., & von Karsa, L. (2010) · Annals of Oncology · doi:10.1093/annonc/mdp471 · Cited by 760
Meijer, C. J. L. M., Berkhof, J., Castle, P. E., Hesselink, A. T., Franco, E. L., Ronco, G., Arbyn, M., Bosch, F. X., Cuzick, J., Dillner, J., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24010 · Cited by 692
The Diagnostic Value of Vaginal Smears in Carcinoma of the Uterus
Papanicolaou, G. N., & Traut, H. F. (1941) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(16)40621-6 · Cited by 620
Muñoz, N., Kjaer, S. K., Sigurdsson, K., Iversen, O.-E., Hernandez-Avila, M., Wheeler, C. M., Perez, G., Brown, D. R., Koutsky, L. A., Tay, E. H., et al. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp534 · Cited by 566
Cross-roads in the classification of papillomaviruses
de Villiers, E.-M. (2013) · Virology · doi:10.1016/j.virol.2013.04.023 · Cited by 540
Management of women who test positive for high-risk types of human papillomavirus: the HART study
Cuzick, J., Szarewski, A., Cubie, H., Hulman, G., Kitchener, H., Luesley, D., McGoogan, E., Menon, U., Terry, G., Edwards, R., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14955-0 · Cited by 510
Chapter 5: Updating the natural history of HPV and anogenital cancer
Moscicki, A.-B., Schiffman, M., Kjaer, S., & Villa, L. L. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.06.018 · Cited by 478
Management of women who test positive for high-risk types of human papillomavirus: the HART study
(2004) · Obstetrics & Gynecology · doi:10.1097/00006250-200404000-00038 · Cited by 427
The human papillomavirus family and its role in carcinogenesis
Tommasino, M. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.11.002 · Cited by 411
Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases
Berman, T. A., & Schiller, J. T. (2017) · Cancer · doi:10.1002/cncr.30588 · Cited by 395
Bray, F., Loos, A. H., McCarron, P., Weiderpass, E., Arbyn, M., Møller, H., Hakama, M., & Parkin, D. M. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0569 · Cited by 370
Screening-Preventable Cervical Cancer Risks: Evidence From a Nationwide Audit in Sweden
Andrae, B., Kemetli, L., Sparen, P., Silfverdal, L., Strander, B., Ryd, W., Dillner, J., & Tornberg, S. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn099 · Cited by 363
Triage of HPV positive women in cervical cancer screening
Wentzensen, N., Schiffman, M., Palmer, T., & Arbyn, M. (2016) · Journal of Clinical Virology · doi:10.1016/j.jcv.2015.11.015 · Cited by 347
Cervical Cancer, Version 2.2015
Koh, W.-J., Greer, B. E., Abu-Rustum, N. R., Apte, S. M., Campos, S. M., Cho, K. R., Chu, C., Cohn, D., Crispens, M. A., Dorigo, O., et al. (2015) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2015.0055 · Cited by 332
Davey, E., Barratt, A., Irwig, L., Chan, S. F., Macaskill, P., Mannes, P., & Saville, A. M. (2006) · The Lancet · doi:10.1016/s0140-6736(06)67961-0 · Cited by 318
Soloman, D. (1989) · Diagnostic Cytopathology · doi:10.1002/dc.2840050318 · Cited by 289
Naucler, P., Ryd, W., Tornberg, S., Strand, A., Wadell, G., Elfgren, K., Radberg, T., Strander, B., Forslund, O., Hansson, B.-G., et al. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn444 · Cited by 287
Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
Arbyn, M., Snijders, P. J. F., Meijer, C. J. L. M., Berkhof, J., Cuschieri, K., Kocjan, B. J., & Poljak, M. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.04.015 · Cited by 275
The diagnostic value of vaginal smears in carcinoma of the uterus. 1941.
Papanicolaou, G. N., & Traut, H. F. (1997) · PubMed · Cited by 273
Siebers, A. G., Klinkhamer, P. J. J. M., Grefte, J. M. M., Massuger, L. F. A. G., Vedder, J. E. M., Beijers-Broos, A., Bulten, J., & Arbyn, M. (2009) · JAMA · doi:10.1001/jama.2009.1569 · Cited by 257
von Karsa, L., Arbyn, M., De Vuyst, H., Dillner, J., Dillner, L., Franceschi, S., Patnick, J., Ronco, G., Segnan, N., Suonio, E., et al. (2015) · Papillomavirus Research · doi:10.1016/j.pvr.2015.06.006 · Cited by 253
Basu, P., Ponti, A., Anttila, A., Ronco, G., Senore, C., Vale, D. B., Segnan, N., Tomatis, M., Soerjomataram, I., Primic Žakelj, M., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31043 · Cited by 251
Meites, E., Kempe, A., & Markowitz, L. E. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14206 · Cited by 240
Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccination
Franco, E. L., Cuzick, J., Hildesheim, A., & de Sanjosé, S. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.061 · Cited by 236
Human Papillomavirus (HPV), HPV-Related Disease, and the HPV Vaccine.
Braaten, K. P., & Laufer, M. R. (2008) · PubMed · Cited by 227
Therapeutic vaccines for high-risk HPV-associated diseases
Chabeda, A., Yanez, R. J. R., Lamprecht, R., Meyers, A. E., Rybicki, E. P., & Hitzeroth, I. I. (2018) · Papillomavirus Research · doi:10.1016/j.pvr.2017.12.006 · Cited by 218
Iversen, O.-E., Miranda, M. J., Ulied, A., Soerdal, T., Lazarus, E., Chokephaibulkit, K., Block, S. L., Skrivanek, A., Nur Azurah, A. G., Fong, S. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.17615 · Cited by 213
HPV-FASTER: broadening the scope for prevention of HPV-related cancer
Bosch, F. X., Robles, C., Díaz, M., Arbyn, M., Baussano, I., Clavel, C., Ronco, G., Dillner, J., Lehtinen, M., Petry, K.-U., et al. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.146 · Cited by 206
Cervical cancer screening by simple visual inspection after acetic acid
Belinson, J. (2001) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(01)01454-5 · Cited by 186
Nygård, J. F., Skare, G. B., & Thoresen, S. Ø. (2002) · Journal of Medical Screening · doi:10.1136/jms.9.2.86 · Cited by 182
Cervical cancer screening in Europe: Quality assurance and organisation of programmes
Elfström, K. M., Arnheim-Dahlström, L., von Karsa, L., & Dillner, J. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.03.008 · Cited by 176
Kitchener, H. C., Gilham, C., Sargent, A., Bailey, A., Albrow, R., Roberts, C., Desai, M., Mather, J., Turner, A., Moss, S., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.01.008 · Cited by 174
Szarewski, A., Cadman, L., Mesher, D., Austin, J., Ashdown-Barr, L., Edwards, R., Lyons, D., Walker, J., Christison, J., Frater, A., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.48 · Cited by 173
Cuschieri, K., Ronco, G., Lorincz, A., Smith, L., Ogilvie, G., Mirabello, L., Carozzi, F., Cubie, H., Wentzensen, N., Snijders, P., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31261 · Cited by 171
Anttila, A., Kotaniemi-Talonen, L., Leinonen, M., Hakama, M., Laurila, P., Tarkkanen, J., Malila, N., & Nieminen, P. (2010) · BMJ · doi:10.1136/bmj.c1804 · Cited by 168
Cervical cancer screening policies and coverage in Europe
Anttila, A., von Karsa, L., Aasmaa, A., Fender, M., Patnick, J., Rebolj, M., Nicula, F., Vass, L., Valerianova, Z., Voti, L., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.07.020 · Cited by 163
Crăciun, I. C., & Băban, A. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.09.016 · Cited by 160
Baandrup, L., Blomberg, M., Dehlendorff, C., Sand, C., Andersen, K. K., & Kjær, S. K. (2013) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31827bd66b · Cited by 158
VALGENT: a protocol for clinical validation of human papillomavirus assays
Arbyn, M., Depuydt, C., Benoy, I., Bogers, J., Cuschieri, K., Schmitt, M., Pawlita, M., Geraets, D., Heard, I., Gheit, T., et al. (2016) · Journal of Clinical Virology · doi:10.1016/j.jcv.2015.09.014 · Cited by 157
Tota, J. E., Bentley, J., Blake, J. M., Coutlée, F., Duggan, M. A., Ferenczy, A. S., Franco, E. L., Fung‐Kee‐Fung, M., Gotlieb, W. H., Mayrand, M., et al. (2017) · Preventive Medicine · doi:10.1016/j.ypmed.2016.11.029 · Cited by 150
European guidelines for clinical management of abnormal cervical cytology, Part 2
Jordan, J. A., Martin‐Hirsch, P. L., Arbyn, M., Schenck, U., Baldauf, J., Silva, D. D., Anttila, A., Nieminen, P., & Prendiville, W. J. (2009) · Cytopathology · doi:10.1111/j.1365-2303.2008.00636.x · Cited by 144
Petry, K. U. (2014) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2014.936683 · Cited by 143
Hilton, S., Hunt, K., Langan, M., Bedford, H. E., & Petticrew, M. P. (2010) · Social Science & Medicine · doi:10.1016/j.socscimed.2009.11.027 · Cited by 143
The impact of liquid-based cytology in decreasing the incidence of cervical cancer.
Gibb, R. K., & Martens, M. G. (2011) · PubMed · Cited by 143
Human papillomavirus in a necessary cause of invasive cervical cancer worldwide
(1999) · Pure Amsterdam UMC · doi:10.1002/(sici)1096-9896(199909)189:1 · Cited by 140
Halec, G., Alemany, L., Lloveras, B., Schmitt, M., Alejo, M., Bosch, F. X., Tous, S., Klaustermeier, J. E., Guimerà, N., Grabe, N., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4405 · Cited by 139
Secondary prevention of cervical cancer
Basu, P. S., Mittal, S., Vale, D. B., & Kharaji, Y. C. (2017) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2017.08.012 · Cited by 138
Lyu, Z., Feng, X., Li, N., Zhao, W., Wei, L., Chen, Y., Yang, W., Ma, H., Yao, B., Zhang, K., et al. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2812-z · Cited by 136
Commercially available molecular tests for human papillomaviruses (HPV): 2015 update
Poljak, M., Kocjan, B. J., Oštrbenk, A., & Seme, K. (2015) · Journal of Clinical Virology · doi:10.1016/j.jcv.2015.10.023 · Cited by 133
Castañón, A., Landy, R., Cuzick, J. M., et al. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001585 · Cited by 132
McSherry, L. A., Dombrowski, S. U., Francis, J. J., Murphy, J., Martin, C. M., O’Leary, J. J., Sharp, L., & ATHENS Group (2012) · Implementation Science · doi:10.1186/1748-5908-7-73 · Cited by 129
Commercially available assays for multiplex detection of alpha human papillomaviruses
Poljak, M., & Kocjan, B. J. (2010) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.10.104 · Cited by 123
Ascunce, N., Salas, D., Zubizarreta, R., Almazán, R., Ibáñez, J., & Ederra, M. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq085 · Cited by 120
HPV vaccination in boys and men
Stanley, M. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.29137 · Cited by 117
Brotherton, J. M. L., & Bloem, P. N. (2017) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2017.08.010 · Cited by 116
Anttila, A., & Ronco, G. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.07.017 · Cited by 115
Gültekin, M., Karaca, M. Z., Küçükyıldız, İ. A., Dundar, S., Boztaş, G., Turan, S. H., Hacikamiloğlu, E., Murtuza, K., Keskinkılıç, B., & Şencan, İ. (2017) · International Journal of Cancer · doi:10.1002/ijc.31212 · Cited by 115
Liquid-based cytology versus conventional Papanicolaou smear in an organized screening program
Strander, B., Andersson‐Ellström, A., Milsom, I., Rådberg, T., & Ryd, W. (2007) · Cancer · doi:10.1002/cncr.22953 · Cited by 113
Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice
Wentzensen, N., Arbyn, M., Berkhof, J. H., Bower, M., Canfell, K., Einstein, M. H., Farley, C., Monsonégo, J., & Franceschi, S. (2016) · International Journal of Cancer · doi:10.1002/ijc.30579 · Cited by 112
Miranda, S., Chaignot, C., Collin, C., Dray‐Spira, R., Weill, A., & Zureik, M. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.06.030 · Cited by 109
Nucleic Acid Tests for the Detection of Alpha Human Papillomaviruses
Poljak, M., Cuzick, J. M., Kocjan, B. J., Iftner, T., Dillner, J., & Arbyn, M. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.04.105 · Cited by 106
Ketelaars, P. J. W., Bosgraaf, R. P., Siebers, A. G., Massuger, L. F. A. G., van der Linden, J. C., Wauters, C. A. P., Rahamat-Langendoen, J. C., van den Brule, A. J. C., IntHout, J., Melchers, W. J. G., et al. (2017) · Preventive Medicine · doi:10.1016/j.ypmed.2017.05.021 · Cited by 104
Enerly, E., Bonde, J. H., Schee, K., Pedersen, H., Lönnberg, S., & Nygård, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151978 · Cited by 103
Romanowski, B., Schwarz, T. F., Ferguson, L., Peters, K., Dionne, M., Behre, U., Schulze, K., Hillemanns, P., Suryakiran, P. V., Thomas, F., et al. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1065363 · Cited by 99
Coleman, D., Day, N., Douglas, G., Farmery, E., Lynge, E., Philip, J., & Segnan, N. (1993) · PubMed · Cited by 95
Raman spectroscopy for screening and diagnosis of cervical cancer
Lyng, F. M., Traynor, D., Ramos, I., Bonnier, F., & Byrne, H. J. (2015) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-015-8946-1 · Cited by 95
Mass screening programmes and trends in cervical cancer in Finland and the Netherlands
van der Aa, M. A., Pukkala, ., Coebergh, J. W. W., Anttila, A., & Siesling, S. (2007) · International Journal of Cancer · doi:10.1002/ijc.23276 · Cited by 95
Vaccarella, S., Franceschi, S., Zaridze, D. G., Poljak, M., Veerus, P., Plummer, M., & Bray, F. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30275-3 · Cited by 95
The current status of the Papanicolaou smear
Shingleton, H. M., Patrick, R., Johnston, W. W., & Smith, R. A. (1995) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.45.5.305 · Cited by 93
Dijkstra, M. G., van Niekerk, D., Rijkaart, D., van Kemenade, F. J., Heideman, D. A. M., Snijders, P. J. F., Meijer, C. J. L. M., & Berkhof, J. H. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0173 · Cited by 92
An overview of cervical cancer epidemiology and prevention in Scandinavia
Pedersen, K., Fogelberg, S., Thamsborg, L. H., Clements, M., Nygård, M., Kristiansen, I. S., Lynge, E., Sparén, P., Kim, J. J., & Burger, E. A. (2018) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.13313 · Cited by 89
George Papanicolaou (1883–1962): Discoverer of the Pap smear
Tan, S., & Tatsumura, Y. (2015) · Singapore Medical Journal · doi:10.11622/smedj.2015155 · Cited by 87
Malila, N. K., Leinonen, M. K., Kotaniemi‐Talonen, L., Laurila, P., Tarkkanen, J., & Hakama, M. (2012) · International Journal of Cancer · doi:10.1002/ijc.27850 · Cited by 84
Cross-sectional Study of Patient- and Physician-Collected Cervical Cytology and Human Papillomavirus
García, F., Barker, B., Santos, C., Brown, E. M., Nuño, T., Giuliano, A. R., & Davis, J. (2003) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(03)00517-9 · Cited by 84
Criteria for Organized Cervical Screening Programs
Hanselaar, A. G. J. M. (2002) · Acta Cytologica · doi:10.1159/000326965 · Cited by 80
HPV vaccination in France: Uptake, costs and issues for the National Health Insurance
Fagot, J., Boutrelle, A., Ricordeau, P., Weill, A., & Allemand, H. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.02.064 · Cited by 79
Need for expanded HPV genotyping for cervical screening
Cuzick, J. M., & Wheeler, C. M. (2016) · Papillomavirus Research · doi:10.1016/j.pvr.2016.05.004 · Cited by 77
Cancer burden in slovenia with the time trends analysis
Zadnik, V., Žakelj, M. P., Lokar, K., et al. (2017) · Radiology and Oncology · doi:10.1515/raon-2017-0008 · Cited by 77
Cox, J. T. (2009) · Journal of Clinical Virology · doi:10.1016/s1386-6532(09)70002-2 · Cited by 76
Towards quality and order in human papillomavirus research
Mühr, L. S. A., Eklund, C., & Dillner, J. (2018) · Virology · doi:10.1016/j.virol.2018.04.003 · Cited by 76
Leinonen, M. K., Campbell, S. H., Ursin, G., Tropé, A., & Nygård, M. (2017) · European Journal of Public Health · doi:10.1093/eurpub/ckx093 · Cited by 75
Virtanen, A., Anttila, A., Luostarinen, T., & Nieminen, P. (2010) · International Journal of Cancer · doi:10.1002/ijc.25581 · Cited by 74
Cervical cancer screening in The Netherlands
van Ballegooijen, M., & Hermens, R. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00317-8 · Cited by 74
Population Impact of HPV Vaccines: Summary of Early Evidence
Hariri, S., Markowitz, L. E., Dunne, E. F., & Unger, E. R. (2013) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2013.09.018 · Cited by 73
Overcoming barriers in HPV vaccination and screening programs
Vorsters, A., Arbyn, M., Baay, M. F. D., Bosch, X. F., de Sanjosé, S., Hanley, S. J. B., Karafillakis, E., Lopalco, P. L., Pollock, K. G. J., Yarwood, J., et al. (2017) · Papillomavirus Research · doi:10.1016/j.pvr.2017.07.001 · Cited by 73
Kivistik, A., Lang, K., Baili, P., Anttila, A., & Veerus, P. (2011) · BMC Women s Health · doi:10.1186/1472-6874-11-43 · Cited by 72
Age-Specific Effectiveness of the Finnish Cervical Cancer Screening Programme
Lönnberg, S., Anttila, A., Luostarinen, T., et al. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0162 · Cited by 72
Public health value of universal HPV vaccination
Audisio, R. A., Icardi, G., Isidori, A. M., Liverani, C. A., Lombardi, A., Mariani, L., Mennini, F. S., Mitchell, D. A., Peracino, A. P., Pecorelli, S., et al. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.07.015 · Cited by 71
The state of the art of cancer control in 30 European countries in 2008
Bastos, J., Peleteiro, B., Gouveia, J., Coleman, M. P., & Lunet, N. (2009) · International Journal of Cancer · doi:10.1002/ijc.24963 · Cited by 71
Cervical Cancer Burden and Prevention Activities in Europe
Kesic, V. I., Poljak, M., & Ивановна, Р. С. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0181 · Cited by 70
Isidean, S. D., Mayrand, M., Ramanakumar, A. V., Gilbert, L., Reid, S. L., Rodrigues, I., Ferenczy, A. S., Ratnam, S., Coutlée, F., Franco, E. L., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30385 · Cited by 69
Inception and Development of the Papanicolaou Stain Method
Chantziantoniou, N., Donnelly, A. D., Mukherjee, M. S., Boon, M. E., & Austin, R. M. (2017) · Acta Cytologica · doi:10.1159/000457827 · Cited by 68
HPV-based cervical cancer screening- facts, fiction, and misperceptions
Wentzensen, N., & Arbyn, M. (2017) · Preventive Medicine · doi:10.1016/j.ypmed.2016.12.040 · Cited by 67
Rossi, P. G., Carozzi, F., Federici, A., Ronco, G., Zappa, M., Franceschi, S., Barca, A., Barzon, L., Baussano, I., Berliri, C., et al. (2016) · Preventive Medicine · doi:10.1016/j.ypmed.2016.11.020 · Cited by 66
Basu, P. S., Meheus, F., Chami, Y., Hariprasad, R., Zhao, F., & Sankaranarayanan, R. (2017) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12183 · Cited by 65
HPV testing in the context of post-treatment follow up (test of cure)
Cuschieri, K. S., Bhatia, R., Cruickshank, M. E., Hillemanns, P., & Arbyn, M. (2015) · Journal of Clinical Virology · doi:10.1016/j.jcv.2015.10.008 · Cited by 63
Gustinucci, D., Rossi, P. G., Cesarini, E. N., Broccolini, M., Bulletti, S., Carlani, A., D’angelo, V., D’amico, M. R., Dato, E. D., Galeazzi, P., et al. (2015) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqv019 · Cited by 61
O’Connor, M., Costello, L., Murphy, J., Prendiville, W. J., Martin, C. M., O'Leary, J., & Sharp, L. (2014) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.12741 · Cited by 60
Jin, X. W., Lipold, L. D., Foucher, J. A., Sikon, A. L., Brainard, J., Belinson, J. L., Schramm, S., Nottingham, K. L., Hu, B., & Rothberg, M. B. (2016) · Journal of General Internal Medicine · doi:10.1007/s11606-016-3772-5 · Cited by 60
Jackowska, M., von Wagner, C., Wardle, J., Juszczyk, D., Łuszczyńska, A., & Waller, J. (2012) · Journal of Family Planning and Reproductive Health Care · doi:10.1136/jfprhc-2011-100144 · Cited by 59
HPV prevalence and HPV-related dysplasia in elderly women
Hermansson, R. S., Olovsson, M., Hoxell, E., & Lindström, A. K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0189300 · Cited by 59
Cervical cancer prevented by screening: Long‐term incidence trends by morphology in N orway
Lönnberg, S., Hansen, B. T., Haldorsen, T., Campbell, S. H., Schee, K., & Nygård, M. (2015) · International Journal of Cancer · doi:10.1002/ijc.29541 · Cited by 55
Shield, K. D., Micallef, C. M., de Martel, C., Heard, I., Mégraud, F., Plummer, M., Vignat, J., Bray, F., & Soerjomataram, I. (2017) · European Journal of Epidemiology · doi:10.1007/s10654-017-0334-z · Cited by 55
Young Hungarian Students’ Knowledge about HPV and Their Attitude Toward HPV Vaccination
Balla, B. C., Terebessy, A., Tóth, E., & Balázs, P. (2016) · Vaccines · doi:10.3390/vaccines5010001 · Cited by 54
Cervical cancer screening in France
Schaffer, P. C., Sancho-Garnier, H., Fender, M., Dellenbach, P., Carbillet, J. P., Monnet, É., Gauthier, G., & Garnier, A. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00312-9 · Cited by 53
Rozemeijer, K., de Kok, I. M. C. M., Naber, S. K., van Kemenade, F. J., Penning, C., van Rosmalen, J., & van Ballegooijen, M. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0998 · Cited by 53
Öz, M., Çetinkaya, N., Apaydın, A., Korkmaz, E., Baş, S., Özgü, E., & Gungor, T. (2016) · Journal of Cancer Education · doi:10.1007/s13187-016-1116-0 · Cited by 52
Tjalma, W. A. A. (2017) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2017.01.009 · Cited by 51
Szucs, T. D., Largeron, N., Dedes, K. J., Rafia, R., & Bénard, S. (2008) · Current Medical Research and Opinion · doi:10.1185/030079908x297826 · Cited by 50
Boiron, L., Joura, E. A., Largeron, N., Prager, B., & Uhart, M. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1483-5 · Cited by 50
de Thurah, L., Bonde, J. H., Lam, J. U. H., & Rebolj, M. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.05.020 · Cited by 50
Cervical screening in Denmark – a success followed by stagnation
Lynge, E., Andersen, B. S., Christensen, J., Ejersbo, D., Jochumsen, K. M., Johansen, T. O., Kristensen, J. K., Larsen, L. G., Mehnert, F., Mikkelsen, E. M., et al. (2017) · Acta Oncologica · doi:10.1080/0284186x.2017.1355110 · Cited by 50
Cervical Cancer Screening in Partly HPV Vaccinated Cohorts – A Cost-Effectiveness Analysis
Naber, S. K., Matthijsse, S. M., Rozemeijer, K., Penning, C., de Kok, I. M. C. M., & van Ballegooijen, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0145548 · Cited by 49
Ronco, G., Zappa, M., Franceschi, S., Tùnesi, S., Caprioglio, A., Confortini, M., Mistro, A. D., Carozzi, F., Segnan, N., Zorzi, M., et al. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.09.008 · Cited by 49
Mass media coverage of HPV vaccination in Romania: a content analysis
a, M. A. P., & ban, A. B. (2014) · Health Education Research · doi:10.1093/her/cyu027 · Cited by 48
Polman, N. J., Veldhuijzen, N. J., Heideman, D. A. M., Snijders, P. J. F., Meijer, C. J. L. M., & Berkhof, J. H. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.309 · Cited by 48
Innovative approaches to cervical cancer screening in low- and middle-income countries
Toliman, P. J., Kaldor, J. M., Tabrizi, S. N., & Vallely, A. J. (2018) · Climacteric · doi:10.1080/13697137.2018.1439917 · Cited by 47
Knowledge of Greek adolescents on human papilloma virus (HPV) and vaccination
Vaidakis, D., Moustaki, I., Zervas, I. M., Barbouni, A., Merakou, K., Chrysi, M. S., Creatsa, G., & Panoskaltsis, T. (2017) · Medicine · doi:10.1097/md.0000000000005287 · Cited by 45
Bal-Yılmaz, H., & Koniak‐Griffin, D. (2017) · Journal of Cancer Education · doi:10.1007/s13187-017-1163-1 · Cited by 45
Lefevere, E., Hens, N., Theeten, H., den Bosch, K. V., Beutels, P., Smet, F. D., & Damme, P. V. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.08.039 · Cited by 43
Current Cervical Carcinoma Screening Guidelines
Schlichte, M. J., & Guidry, J. A. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4050918 · Cited by 43
Altobelli, E., & Lattanzi, A. (2015) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000374 · Cited by 43
Burton-Jeangros, C., Fargnoli, V., & Petignat, P. (2015) · International Journal of Women's Health · doi:10.2147/ijwh.s90772 · Cited by 42
Costa, S., Venturoli, S., Origoni, M., Preti, M., Mariani, L., Cristoforoni, P. M., & Sandri, M. T. (2015) · ecancermedicalscience · doi:10.3332/ecancer.2015.528 · Cited by 42
Estimating the long-term effects of HPV vaccination in Germany
Horn, J., Damm, O., Kretzschmar, M., Deleré, Y., Wichmann, O., Kaufmann, A. M., Garbe, E., Krämer, A., Greiner, W., & Mikolajczyk, R. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.03.006 · Cited by 41
Primary Prevention of HPV through Vaccination: Update on the Current Global Status
Brotherton, J. M. L., ZUBER, P. L. F., & Bloem, P. N. (2016) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-016-0165-z · Cited by 41
Azerkan, F., Widmark, C., Sparén, P., Weiderpass, E., Tillgren, P., & Faxelid, E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0107624 · Cited by 40
Geyer, S., Jaunzeme, J., & Hillemanns, P. (2014) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-014-3421-3 · Cited by 40
Nowakowski, A. M., Cybulski, M., Śliwczyński, A. M., Chil, A., Teter, Z., Seroczyński, P., Arbyn, M., & Anttila, A. (2015) · BMC Cancer · doi:10.1186/s12885-015-1242-9 · Cited by 40
Huijsmans, C. J. J., Geurts-Giele, W. R. R., Leeijen, C., Hazenberg, H. L. C. M., van Beek, J., Wild, C., van der Linden, J. C., & van den Brule, A. (2016) · BMC Cancer · doi:10.1186/s12885-016-2961-2 · Cited by 40
Huchko, M. J., Sneden, J., Zakaras, J. M., Smith‐McCune, K., Sawaya, G. F., Maloba, M., Bukusi, E. A., & Cohen, C. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118568 · Cited by 39
Karjalainen, L., Anttila, A., Nieminen, P., Luostarinen, T., & Virtanen, A. (2016) · BMC Cancer · doi:10.1186/s12885-016-2246-9 · Cited by 39
Cervical cancer prevention and screening: the role of human papillomavirus testing
Aref‐Adib, M., & Freeman‐Wang, T. (2016) · The Obstetrician & Gynaecologist · doi:10.1111/tog.12279 · Cited by 37
Idehen, E. E., Korhonen, T., Castaneda, A. E., Juntunen, T., Kangasniemi, M. K., Pietilä, A., & Koponen, P. (2017) · BMC Women s Health · doi:10.1186/s12905-017-0375-1 · Cited by 37
Williams, D., Davies, M., Fiander, A., Farewell, D. M., Hillier, S., & Brain, K. E. (2017) · Health Expectations · doi:10.1111/hex.12544 · Cited by 36
Radde, K., Gottschalk, A., Bussas, U., Schülein, S., Schriefer, D., Seifert, U., Neumann, A., Kaiser, M., Blettner, M., & Klug, S. J. (2016) · International Journal of Cancer · doi:10.1002/ijc.30146 · Cited by 35
Cost-effectiveness of human papillomavirus vaccination in Germany
Damm, O., Horn, J., Mikolajczyk, R., Kretzschmar, M., Kaufmann, A. M., Deleré, Y., Ultsch, B., Wichmann, O., Krämer, A., & Greiner, W. (2017) · Cost Effectiveness and Resource Allocation · doi:10.1186/s12962-017-0080-9 · Cited by 35
Screening for cervical cancer: when theory meets reality
Nygård, M. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-240 · Cited by 34
Cervical cancer screening practices in central and eastern Europe in 2012.
Maver, P. J., Seme, K., Korać, T., Димитров, Г., Döbrőssy, L., Eņģele, L., Iljazović, E., Kesic, V. I., Kostova, P., Laušević, D., et al. (2013) · PubMed · Cited by 34
Onuki, M., Matsumoto, K., Sakurai, M., Ochi, H., Minaguchi, T., Satoh, T., & Yoshikawa, H. (2015) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2016.27.e3 · Cited by 34
HPV-Testing in Follow-up of Patients Treated for CIN2+ Lesions
Mariani, L., Sandri, M. T., Preti, M., Origoni, M., Costa, S., Cristoforoni, P. M., Bottari, F., & Sideri, M. G. (2015) · Journal of Cancer · doi:10.7150/jca.13503 · Cited by 34
Spontaneous and Vaccine-Induced Clearance of Mus Musculus Papillomavirus 1 Infection
Jiang, R. T., Wang, J. W., Peng, S., Huang, T., Wang, C., Cannella, F., Chang, Y., Viscidi, R. P., Best, S. R., Hung, C., et al. (2017) · Journal of Virology · doi:10.1128/jvi.00699-17 · Cited by 34
Poor Cervical Cancer Screening Attendance and False Negatives. A Call for Organized Screening
Castillo, M., Astudillo, A., Clavero, O., Velasco, J., Ibáñez, R., & de Sanjosé, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161403 · Cited by 33
HPV prevalence and type distribution in Cypriot women with cervical cytological abnormalities
Krashias, G., Koptides, D., & Christodoulou, C. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2439-0 · Cited by 33
Role of HPV DNA testing in modern gynaecological practice
Ronco, G., & Rossi, P. G. (2017) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2017.08.002 · Cited by 33
Impact of HPV vaccination with Gardasil® in Switzerland
Jacot‐Guillarmod, M., Pasquier, J., Greub, G., Bongiovanni, M., Achtari, C., & Sahli, R. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2867-x · Cited by 33
Follow up with HPV test and cytology as test of cure, 6 months after conization, is reliable
Asciutto, K. C., Hénic, E., Darlin, L., Forslund, O., & Borgfeldt, C. (2016) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.12960 · Cited by 32
Tjalma, W. A. A., Kim, E., & Vandeweyer, K. (2017) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2017.01.010 · Cited by 32
Lamin, H., Eklund, C., Elfström, K. M., Carlsten‐Thor, A., Hortlund, M., Elfgren, K., Törnberg, S., & Dillner, J. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014788 · Cited by 32
Genital HPV in Children and Adolescents: Does Sexual Activity Make a Difference?
Bacopoulou, F., Karakitsos, P., Kottaridi, C., Stefanaki, C., Deligeoroglou, E., Theodoridou, K., Chrousos, G. P., & Michos, A. G. (2015) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2015.08.010 · Cited by 31
Isidean, S. D., Mayrand, M., Ramanakumar, A. V., Rodrigues, I., Ferenczy, A. S., Ratnam, S., Coutlée, F., & Franco, E. L. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0705 · Cited by 31
Petry, K. U., Barth, C., Wasem, J., & Neumann, A. (2017) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2017.03.029 · Cited by 31
Qendri, V., Bogaards, J. A., & Berkhof, J. H. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix272 · Cited by 31
Modified ultrafast Papanicolaou staining technique: A comparative study
Thakur, M., & Guttikonda, V. (2017) · Journal of Cytology · doi:10.4103/joc.joc_23_16 · Cited by 31
Nowakowski, A. M., Wojciechowska, U. E., Wieszczy, P., Cybulski, M., Kaminski, M. F., & Didkowska, J. A. (2017) · European Journal of Epidemiology · doi:10.1007/s10654-017-0291-6 · Cited by 31
Population-based organized cervical cancer screening pilot program in France
Hamers, F. F., Duport, N., & Beltzer, N. (2017) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000365 · Cited by 29
Costa, A. R., Silva, S., Ferreira, P. M., Villaverde‐Cabral, M., Santos, O., do Carmo, I., Barros, H., & Lunet, N. (2016) · Health Expectations · doi:10.1111/hex.12450 · Cited by 28
Latsuzbaia, A., Tapp, J., Nguyen, T., Fischer, M., Arbyn, M., Weyers, S., & Mossong, J. (2016) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2016.04.011 · Cited by 27
Surveillance of effects of HPV vaccination in Belgium
Arbyn, M., Broeck, D. V., Benoy, I. H., Bogers, J., Depuydt, C., Praet, M. M., Sutter, P. D., Hoorens, A., Hauben, E. I., Poppe, W. A. J., et al. (2016) · Cancer Epidemiology · doi:10.1016/j.canep.2015.12.011 · Cited by 26
Viviano, M., Catarino, R., Jeannot, É., Boulvain, M., Undurraga, M., Vassilakos, P., & Petignat, P. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.111 · Cited by 26
Östensson, E., Fröberg, M., Levál, A., Hellström, A., Bäcklund, L. M., Zethraeus, N., & Andersson, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139062 · Cited by 25
The Next Steps in Cervical Screening
Sankaranarayanan, R., Qiao, Y., & Keita, N. (2015) · Women s Health · doi:10.2217/whe.14.70 · Cited by 24
Laboratory audit as part of the quality assessment of a primary HPV-screening program
Hortlund, M., Sundström, K., Lamin, H., Hjerpe, A., & Dillner, J. (2015) · Journal of Clinical Virology · doi:10.1016/j.jcv.2015.12.007 · Cited by 24
Võrno, T., Lutsar, K., Uusküla, A., Padrik, L., Raud, T., Reile, R., Nahkur, O., & Kiivet, R. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.08.083 · Cited by 24
Organised screening for cervical cancer in France: a cost-effectiveness assessment
Barré, S., Massetti, M., Leleu, H., & BELS, F. D. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014626 · Cited by 24
Awareness of HPV infection and attitudes toward HPV vaccination among Latvian adolescents
Patel, H., Pčolkina, K., Strazdiņa, K., Viberga, I., Sherman, S. M., Tincello, D. G., Redman, C. W. E., Rezeberga, D., & Moss, E. L. (2017) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12117 · Cited by 23
Cervical HPV type-specific pre-vaccination prevalence and age distribution in Croatia
Sabol, I., Gašperov, N. M., Matovina, M., Božinović, K., Grubišić, G., Fistonić, I., Belci, D., Alemany, L., Džebro, S., Dominis, M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180480 · Cited by 23
Lefevere, E., Theeten, H., Hens, N., Smet, F. D., Top, G., & Damme, P. V. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.07.088 · Cited by 22
Westre, B., Giske, A., Guttormsen, H., Sørbye, S. W., & Skjeldestad, F. E. (2016) · BMC Clinical Pathology · doi:10.1186/s12907-016-0032-x · Cited by 22
Karamanidou, C., & Dimopoulos, Κ. (2016) · BMC Public Health · doi:10.1186/s12889-016-2831-5 · Cited by 22
Perception and use of Pap smear screening among rural and urban women in Romania
Grigore, M., Popovici, R. M., Pristavu, A. I., Grigore, A. M., Matei, M. C., & Gafițanu, D. (2017) · European Journal of Public Health · doi:10.1093/eurpub/ckx112 · Cited by 22
Cervical cancer screening with HPV testing in the Valcamonica (Italy) screening programme
Pasquale, L., Rossi, P. G., Carozzi, F., Pedretti, C., Ruggeri, C., Scalvinoni, V., Cottini, M., Tosini, A., Morana, C., Chiaramonte, M., et al. (2014) · Journal of Medical Screening · doi:10.1177/0969141314561707 · Cited by 21
Xi, L. F., SCHIFFMAN, M. H., Koutsky, L. A., Hughes, J. P., Hulbert, A., Shen, Z., Galloway, D. A., & Kiviat, N. B. (2016) · International Journal of Cancer · doi:10.1002/ijc.30164 · Cited by 21
Skufca, J., Ollgren, J. P., Ruokokoski, E., Lyytikäinen, O., & Nohynek, H. (2017) · Papillomavirus Research · doi:10.1016/j.pvr.2017.03.001 · Cited by 21
Makkonen, P., Heinävaara, S. H., Sarkeala, T. M., & Anttila, A. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.09.010 · Cited by 21
Dobec, M., Bannwart, F., Kilgus, S., Kaeppeli, F., & Cassinotti, P. (2011) · Journal of Medical Virology · doi:10.1002/jmv.22126 · Cited by 20
Present and future of cervical cancer prevention in Spain: a cost-effectiveness analysis
Georgalis, L., de Sanjosé, S., Esnaola, M., Bosch, F. X., & Díaz, M. (2015) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000202 · Cited by 20
Maggino, T., Sciarrone, R., Murer, B., Rossi, M. R. D., Fedato, C., Maran, M., Lorio, M., Soldà, M., Zago, F., Rossi, P. G., et al. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.216 · Cited by 20
Lurie, S., Mizrachi, Y., Chodick, G., Katz, R., & Schejter, E. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.06.001 · Cited by 20
Andreassen, T., Melnic, A., Figueiredo, R. A. D. O., Moen, K., Șuteu, O., Nicula, F., Ursin, G., & Weiderpass, E. (2018) · International Journal of Public Health · doi:10.1007/s00038-018-1107-5 · Cited by 20
Cervical cancer screening in Belgium and overscreening of adolescents
Kerrebroeck, H. V., & Makar, A. P. (2015) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000155 · Cited by 19
The end of the decline in cervical cancer mortality in Spain: trends across the period 1981–2012
Cervantes-Amat, M., López‐Abente, G., Aragonés, N., Pollán, M., Pastor‐Barriuso, R., & Pérez‐Gómez, B. (2015) · BMC Cancer · doi:10.1186/s12885-015-1306-x · Cited by 19
Managing Uncertainty: Healthcare Professionals' Meanings Regarding the HPV Vaccine
Todorova, I. L. G., Alexandrova‐Karamanova, A., Panayotova, Y., Dimitrova, E., & Kotzeva, T. (2013) · International Journal of Behavioral Medicine · doi:10.1007/s12529-013-9343-9 · Cited by 19
Jančar, N., Ponikvar, B. M., & Tomšič, S. (2016) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2016.06.005 · Cited by 19
Baltzer, N., Sundström, K., Nygård, J. F., Dillner, J., & Komorowski, J. (2017) · International Journal of Cancer · doi:10.1002/ijc.30725 · Cited by 19
Metadata
- Authors
- Chrysostomou, A. C., Stylianou, D. C., Constantinidou, A., & Kostrikis, L. G.
- Venue
- Viruses
- Publisher
- MDPI AG
- Published
- 2018-12-19
- Volume
- 10
- Issue
- 12
- Pages
- 729
- ISSN
- 1999-4915 (ISSN-L)
- OpenAlex
- W2904344046
- Cited by
- 258
- References
- 247
- FWCI
- 16.02
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.